Safety and Immunogenicity Evaluation of Inactivated whole-virus-SARS-COV-2 In Mice As Emerging Vaccine Development In Egypt
A. A. Ali, M. A. Saad, I. Ryan, M. Amin, M. I. Shindy, W. A. Hassan, M. Samir, A. A. Khattab, S. S. Abdelgayed, M. G. Seadawy, F. M. Fahmy, K. Amer
This study evaluates the safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in mice, showing high antibody titers and complete protection against viral challenge.
bioRxiv · Mar 1, 2021Immunology